Concepedia

Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells

Koji Harada, Shinichi Kawaguchi, Supriatno, Tomitaro Onoue, Hideo Yoshida, Mitsunobu Sato

Oral Oncology · 2004 · 49 citations · 15 references

DOI

Concepts

References

15

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

G. Gordon Steel, Michael Peckham · International Journal of Radiation Oncology*Biology*Physics · 1979 · 906 citations

, , +14

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

Tetsuhiko Shirasaka, Yuji Shimamato, Hideyuki Ohshimo et al. · Anti-Cancer Drugs · 1996 · 824 citations

, , +16

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations

, , +11

Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.

Tetsuhiko Shirasaka, Yuji Shimamoto, Masakazu Fukushima · PubMed · 1993 · 350 citations

, , +11

A Neoplastic Epithelial Duct Cell Line Established From An Irradiated Human Salivary Gland

Kanemitsu Shirasuna, Mitsunobu Sato, Tadashi Miyazaki · Cancer · 1981 · 320 citations

, , +17